References
- Serruys P., Luijten H., Beatt K. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. J Am Coll Cardiol. 1988; 77: 361–371
- Eriksen U. H., Amtorp O., Bagger J. P., et al. Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty. Am Heart J. 1995; 130: 1–8
- Buchan AMJ, Sikora LKJ, Levy J. G., McLntosh CHS, Dyck I., Brown JC. An immunocytochemical investigation with monoclonal antibodies to somatostatin. Histochemistry 1985; 83: 175–180
- Lamberts SWJ, Krenning E. P., Reubi JC. The role of somatostatin and its analogues in the diagnosis and treatment of tumors. Endocr Rev. 1991; 12: 450–482
- Vidal C., Rauly I., Zeggari M., et al. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells. Mol Pharmacol. 1994; 45: 97–104
- Grant M. B., Wargovich T. J., Ellis E. A., et al. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells: a potential treatment for restenosis?. Circulation 1994; 89: 1511–1517
- Lundergan C., Foegh M. L., Vargas R., et al. Inhibition of myointimal proliferation of the rat carotid artery by the peptides angiopeptin and BIM 23034. Atherosclerosis 1989; 80: 49–55
- Conte J. V., Foegh M. L., Calcagno D. Peptide inhibition of myointimal proliferation following angioplasty in rabbits. Transpl Proc. 1989; 21: 3686–3688
- Hong M. K., Bhatti T., Mathews B. J., et al. The effect of porous infusion balloon-delivered angiopeptin on myointimal hyperplasia after balloon injury in the rabbit. Circulation 1993; 88: 638–648
- Stemerman M. B., Spaet T. H., Pitlick J., Lejnieks I., Tiel ML. Intimal healing: the pattern of reendothelialization and intimal healing. Am J Pathol. 1977; 87: 125–137
- Eguchi H., Okadoune K., Shinsuke M., Takashi Y., Sugimachi K. Significance of the endothelial lining in prevention of intimal thickening of autogenous vein grafts in dogs. J Surg Res. 1991; 50: 179–187
- Leszczynski D., Dunsky K., Joseph M. D., Zhao Y., Foegh ML. Angiopeptin, a somatostatin-14 analogue decreases adhesiveness of rat leukocytes to unstimulated and IL-1 beta-activated rat heart endothelial cells. Life Sci. 1995; 57: PL217–223
- Leszczynski D., Joseph M. D., Founier R. S., Foegh M. L. Angiopeptin, the octapeptide analogue of somatostatin, decreases rat heart endothelial cell adhesiveness for mononuclear cells. Regul Pept. 1993; 43: 131–140
- Shimokawa H., Aarhos L. L., Vanhoutte PM. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res. 1987; 61: 256–277
- Light J. T., Bellan J. A., Chen I. L., et al. Angiopeptin enhanced acetylcholine-induced relaxation and inhibits intimal hyperplasia after vascular injury. Am J Physiol. 1993; 265: H1265–H1274
- Emanuelsson H., Beat W., Bagger J-P, et al. Long-term effects of angiopeptin treatment in coronary angioplasty: reduction of clinical events but not angiographic restenosis. Circulation 1995; 91: 1689–1696
- Kent K. M., Williams D. O., Cassagneau B., et al. Double blind controlled trial of the effect of angiopeptin on coronary restenosis following balloon angioplasty. Circulation 1993; 88: 1506, (Abst)